The top 10 signs of adverse drug events in older people

Monash University

Thursday, 18 July, 2024


The top 10 signs of adverse drug events in older people

Older people who use psychotropic medications can be significantly harmed by adverse events and side-effects.

Psychotropic medications such as antipsychotics, benzodiazepines and antidepressants are commonly used to manage a range of mental health conditions including depression, anxiety and insomnia. As such, monitoring for signs and symptoms suggestive of adverse drug events should be routine in long-term aged care facilities.

A Monash University-led study has now uncovered the top 10 signs and symptoms carers need to be aware of.

So what should care nurses be looking for?

Researchers from the Centre for Medicine Use and Safety (CMUS), within the Monash Institute of Pharmaceutical Sciences (MIPS), have led a new international consensus study and found the top 10 signs and symptoms to be recent falls, daytime drowsiness or sleepiness, abnormal movements, confusion or disorientation, balance problems, dizziness, postural hypotension (ie, dizziness caused by low blood pressure when standing up), reduced self-care, restlessness, and dry mouth.

The study involved geriatricians, psychiatrists, clinical pharmacologists, general practitioners, pharmacists, nurses and carers from 13 different Asia–Pacific, European and North American countries.

The study’s lead author, CMUS PhD candidate and Monash Health pharmacist Brigid McInerney, said the top 10 signs and symptoms identified by the international expert panel were considered to reduce quality of life or cause significant resident harm and were observable or measurable by nurses and care workers.

“Medication safety is a national health priority area — and residents of aged care facilities are at high risk of experiencing medication-related harm. Our findings will empower nurses and aged care workers to identify when residents are experiencing side-effects,” she said.

New guidelines in place

CMUS has recently led the development of Australia’s new Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care.

These guidelines recommend that all residents who use an antipsychotic, benzodiazepine or antidepressant medication for changed behaviours in people living with dementia should have a structured adverse event monitoring protocol in place. This new international consensus study provides further guidance about which signs and symptoms nurses and aged care workers should proactively monitor.

“Australia’s new guidelines recommend all health professionals involved in prescribing, dispensing or administering a psychotropic medication for a resident should be familiar with the adverse event monitoring protocol, and this protocol should be available to residents and their carers’ as well,” McInerney said.

CMUS researchers have developed an adverse event monitoring tool, based on this study, for use by residential care nurses or care workers to detect signs and symptoms of adverse events in residents who use psychotropic medications.

“We anticipate that this short, easy-to-use checklist can be for routine use in different residential aged care facilities. This may facilitate proactive monitoring and early detection of adverse drug events and avoid further medication-related harm.”

Image credit: iStock.com/Daisy-Daisy

Related Articles

How hospital stays could be reduced for older patients

New research conducted by Flinders University has revealed one key way that hospital stays could...

In conversation with Janet Phillips: dying with dignity

Victoria faces a dire funding crisis in aged care palliative services, raising concerns that many...

Counting the minutes on allied health care

Currently, Australians receiving aged care are, on average, only obtaining eight minutes of...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd